• (-)-Blebbistatin and Mechanomemory: Evidence Gaps

  2026-10-12

  A 2025 study links intermittent mechanical stress with F-actin accumulation, YAP nuclear translocation, and Ctgf expression in Chinese hamster ovary cells. Its findings support an actomyosin-dependent model of mechanomemory, but they do not independently establish the effects, specificity, or applicability of (-)-Blebbistatin across cell types or biological outcomes.

• HLY78 and Wnt Signaling: Evidence and Limits

  2026-10-12

  Available information describes HLY78 as a ligand-dependent Wnt/β-catenin pathway modulator, while a 2024 mouse and cell-model study links reduced SFRP1 with neutrophil infiltration and fibrosis in oral submucous fibrosis. These lines of evidence are mechanistically related but do not establish that HLY78 affects oral fibrosis or has clinical utility.

• HOXC8, Caspase-1, and Pyroptosis in Lung Cancer

  2026-10-11

  A source-grounded overview of a 2025 Cell Death & Disease study linking HOXC8 depletion to caspase-1-associated pyroptosis in non-small cell lung cancer models. The discussion separates the paper’s findings from supplier descriptions of Z-YVAD-FMK and emphasizes pharmacological, model-specific, and translational limitations.

• Trolox and the Logic of Lipid Oxidation Evidence

  2026-10-10

  Trolox is more than a generic antioxidant benchmark: it can help researchers distinguish broad redox protection from lipid-peroxidation-driven cell death. This evidence-centered analysis connects Trolox with ferroptosis research while defining its limits in oxidative injury, neurodegeneration, cancer biology, and screening studies.

• Human iPSC Intestinal Organoids for Pharmacokinetics

  2026-10-09

  Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be maintained, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated cytochrome P450 and transporter activities, supporting their evaluation as a human-relevant model for pharmacokinetic studies.

• Light-Controlled RNA Release for Gene Therapy

  2026-10-09

  The reference study presents a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation level. In cellular and animal models, the platform enabled reversible, light-dependent regulation of gene therapy activity, including applications in diet-induced obesity and retinal neovascular disease, while also highlighting important translational limitations.

• AGEs, ARL8, and Macrophage Control of S. aureus

  2026-10-08

  Xie et al. identify an ARL8-dependent defect in autophagosome–lysosome fusion that helps explain why advanced glycation end products impair macrophage clearance of intracellular Staphylococcus aureus. The study’s main implication is interpretive as well as mechanistic: increased autophagosome accumulation may indicate blocked autophagic flux rather than improved antibacterial activity.

• FH1 Small Molecule: Hepatocyte Maturation

  2026-10-08

  FH1 is a small molecule described for enhancing cultured hepatocyte function during iPS cell differentiation to hepatocyte-like cells. Supplier-reported benchmarks include higher albumin secretion, increased CYP3A4, reduced AFP, and more pronounced hepatocyte morphology, but the available evidence does not establish a molecular target or clinical efficacy.

• SCD1 Deficiency and Ferroptosis in Chicken Liver Cells

  2026-10-07

  A 2026 Poultry Science study links SCD1 loss with greater ferroptosis susceptibility in chicken embryonic liver cells, connecting fatty-acid desaturation with lipid peroxidation, iron imbalance, antioxidant capacity, and mitochondrial injury. The findings support a protective role for SCD1 in this avian cell model, while remaining limited by the in vitro design and the use of molecular and pharmacological response markers rather than whole-animal validation.

• Tamsulosin: From α1A Biology to Translational Insight

  2026-10-07

  A source-grounded analysis of Tamsulosin that connects α1A-adrenergic pharmacology with smooth muscle biology, evidence synthesis, translational study design, and the boundaries of postoperative urinary retention research.

• Nicotine Signaling and Chronic Kidney Disease

  2026-10-06

  Jain and Jaimes synthesize clinical and experimental evidence that nicotine may contribute directly to chronic kidney disease progression through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and profibrotic signaling. The review’s main contribution is to separate nicotine-mediated biology from the broader effects of cigarette smoke while identifying important limits in translating animal and short-term human findings into clinical conclusions.

• Cy3-dCTP: Reading Fluorescent DNA Evidence

  2026-10-06

  Cy3-dCTP enables direct fluorescent labeling of DNA and cDNA, but its strongest value emerges when signal is interpreted alongside polymerase accessibility and molecular architecture. This article connects Cyanine 3-deoxycytidine triphosphate with DNA-framework research while clarifying what the evidence does—and does not—demonstrate.

• HCN4 Channels Couple Temperature to Heart Rate

  2026-10-05

  A 2023 bioRxiv preprint identifies a conserved M407/Y409 motif in HCN4 as a key determinant of heat-dependent pacemaker-current and heart-rate responses. By connecting channel mutagenesis with sinoatrial-node cells, isolated hearts, and mouse models, the study proposes a mechanistic link between temperature sensing and cardiac excitability while remaining limited by its preprint status and model-specific evidence.

• C34 TLR4 Inhibitor: Evidence, Context and Limits

  2026-10-05

  An evidence-focused overview of C34 as a TLR4 inhibitor, covering its reported selectivity, research relevance in macrophages, enterocytes and neuroinflammation, comparison with Taxus chinensis findings, and key limitations in translating supplier-level claims into validated biology.

• Phosphatase Inhibitor Cocktail and Signal Fidelity

  2026-10-04

  Phosphatase Inhibitor Cocktail K1015 supports protein phosphorylation preservation across analytical workflows. This article examines how phosphatase control can strengthen interpretation of AMPK-linked liver injury research while clarifying evidence limits and assay context.

8121 records 1/542 page Next 12345 下5页 Last page